Fibrinolysis inhibition and glycocalyx injury mediate glucocorticoid-related thrombotic risk: pathway analysis and a plasma protein score
AbstractAim: Adverse effects of glucocorticoids (GCs) vary widely and are poorly explained by cumulative dose. We characterised a GC response subtype defined by suppressed fibrinolysis and endothelial glycocalyx injury (CTS2), quantified the risk carried by these pathways and developed a plasma protein score. Methods: Consensus clustering of nine GC-exposure transcriptomic datasets (1,042 samples) defined response subtypes and the CTS2 score. In the UK Biobank, 46,782 new GC users and 46,782 matched non-users were followed for venous thromboembolism (VTE), death and annual decline in estimated glomerular filtration rate (eGFR). Four-way causal mediation estimated the proportions mediated by plasminogen activator inhibitor-1 (PAI-1) and syndecan-1 (SDC-1). A ten-protein score (GHPS) was built by elastic net and validated externally. Results: CTS2 accounted for 28.7% of users and showed up-regulation of SERPINE1, HPSE, MMP9 and ANGPT2 with blunted anti-inflammatory transcription. Each standard deviation (SD) increase in the CTS2 score was associated with higher risks of VTE (hazard ratio [HR] 1.42, 95% confidence interval [CI] 1.28–1.58) and death (1.31, 1.19–1.44) and with a 1.86 mL/min/1.73 m2 greater annual eGFR decline (1.48–2.24). PAI-1 and SDC-1 mediated 28.8% and 20.6% of the VTE effect (joint 47.6%, 38.5–57.2). The GHPS reached areas under the curve of 0.729 (0.703–0.755) and 0.738 (0.701–0.775) in two external cohorts, with a net reclassification improvement of 0.142. Conclusion: Harmful GC signalling reflects a decoupled receptor state more than cumulative dose. Fibrinolysis inhibition and glycocalyx injury explain nearly half of the thrombotic risk, and the GHPS provides a measurable proxy for mechanism-guided risk stratification.
Authors
- Huiling Xie (ORCID: https://orcid.org/0009-0005-3182-6811)
- Huozhao Ruan
- Xin Kang
- Dong Yang (ORCID: https://orcid.org/0009-0005-0852-855X)
Institutions
- Southern Medical University (CN)
Publication Details
- Journal
- Authorea
- Published
- 2026-11-19
- DOI
- https://doi.org/10.22541/authorea.15012478/v1
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- preprint